Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Proximagen discloses novel PAR2 receptor antagonists

Aug. 21, 2012

Collaboration yields novel prostanoid EP1 receptor antagonists

Aug. 21, 2012

New cathepsin A inhibitors patented by Sanofi

Aug. 21, 2012

Novartis divulges new glutamate receptor antagonists

Aug. 21, 2012

Gilead Sciences presents new candidate therapeutics for hepatitis

Aug. 21, 2012

Novel candidate cancer gene therapies developed in U.S.

Aug. 20, 2012

New potential ocular medications designed in Korea

Aug. 20, 2012

Lykera Biomed reports novel S100-P-directed antibodies

Aug. 20, 2012

Research at Zafgen yields new candidate obesity drugs

Aug. 20, 2012

Eisai divulges new PGE2/EP4 receptor signaling suppressors

Aug. 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...